Search Results 71-80 of 16637 for primary sclerosing cholangitis
... Primary Sclerosing Cholangitis (PSC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Mayo Clinic researchers were among the first to describe primary sclerosing cholangitis. Other research done at Mayo has helped to refine diagnostic tests, ...
The purpose of this study is to evaluate the effectiveness and safety of obeticholic acid in patients with primary sclerosing cholangitis, evaluating its ...
Primary biliary cholangitis is a type of liver disease that damages the bile ducts. Early recognition and treatment may help prevent complications.
Primary biliary cholangitis is a relatively rare condition, occurring in less than 1 in 2,000 people. Mayo Clinic doctors typically see around 900 people a year ...
Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation · Overview · Participation ...
... primary sclerosing cholangitis in the present can look forward to a brighter future. It's both a mouthful and a ruthless condition: primary sclerosing ...
— Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research ...
The purpose of this study is to evaluate the safety and effectiveness of curcumin used in patients with primary sclerosing cholangitis. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.